NCT07560267 Efficacy of Ultrasound-Guided Erector Spinae Block for Postoperative Pain Management in Nephrectomy
| NCT ID | NCT07560267 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bangladesh Medical University |
| Condition | Erector Spinae Plane Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2025-09-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to evaluate the effectiveness of the ultrasound-guided erector spinae plane (ESP) block in managing postoperative pain for patients undergoing open nephrectomy (kidney removal surgery). The study will compare this new technique to traditional pain management methods, such as opioid medications, to assess whether the ESP block reduces pain and the need for opioids after surgery. Patients will be randomly assigned to one of two groups: Group C will receive conventional pain relief methods, including opioids. Group E will receive the ultrasound-guided ESP block in addition to general anesthesia. The main goals are to determine: How much pain relief each method provides, measured using a visual analog scale (VAS). The total amount of opioids required during the first 24 hours post-surgery. Additional measurements will include monitoring vital signs like heart rate, blood pressure, and oxygen levels. This study will help find safer and more effective ways to manage pain after nephrectomy, reducing the reliance on opioids and improving patient recovery
Eligibility Criteria
Inclusion Criteria: * Adult patients aged 18 to 64 years * Scheduled for open nephrectomy (radical or partial) under general anesthesia * ASA physical status I-II (American Society of Anesthesiologists classification) Exclusion Criteria: * Allergy to local anesthetics. * Local infection or inflammation at the site of the Block placement. * Presence of anatomical deformities in the spine * Coagulopathy or any bleeding disorder. * Pregnancy or breastfeeding women. * History of severe chronic pain syndrome
Contact & Investigator
AKM Akhtaruzzaman, MD
STUDY DIRECTOR
Bangladesh Medical University
Frequently Asked Questions
Who can join the NCT07560267 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Erector Spinae Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07560267 currently recruiting?
Yes, NCT07560267 is actively recruiting participants. Contact the research team at kazimahzabinarin@bsmmu.edu.bd for enrollment information.
Where is the NCT07560267 trial being conducted?
This trial is being conducted at Dhaka, Bangladesh.
Who is sponsoring the NCT07560267 clinical trial?
NCT07560267 is sponsored by Bangladesh Medical University. The principal investigator is AKM Akhtaruzzaman, MD at Bangladesh Medical University. The trial plans to enroll 66 participants.